focus -WSS

focus

author：hotspot 2025-10-01 12:11:21 - browse：2284

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： ALS treatment from Biogen, Ionis fails in study

focus

WSS

Interest rates are at a 22

Timeline: Special counsel's probe into Trump's handling of classified documents

VC firm RA Capital starts a new synthetic biology incubator

Supreme Court to hear if Covid misinformation is protected speech

Biden to sign 'historic' executive order on how US military handles sexual assault cases

Biden jokes that Republicans may impeach him because inflation is starting to cool down

knowledge

focus

explore

Virginia high school admissions case could be legal follow

Galapagos to make CAR

Hollywood unions extend contract negotiations for actors

Public health communication lessons from Covid

Psychedelics group wrestles with new pharma identity

Fertility clinic egg and embryo storage is a disaster

Novavax promises a turnaround & Lilly roils the obesity market

Behind warning on Apellis’s eye drug lies a conflict of interest

Supreme Court strikes down use of affirmative action

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

hotspot

Marc Tessier

As the dark side of IVF slowly comes into focus, even more transparency is needed

Novo Nordisk testing Wegovy against alcohol

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

As the dark side of IVF slowly comes into focus, even more transparency is needed

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

entertainment

focus

hotspot

explore